News Releases

<< Back
Waters Corporation Presentation at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference to Be Audio Webcast Live

MILFORD, Mass.--(BUSINESS WIRE)--Feb. 1, 2008--Waters Corporation (NYSE:WAT) John Ornell, Chief Financial Officer, will speak to the investment community at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference at the Grand Hyatt Hotel in New York on Tuesday, February 5th, at 3:20 p.m. eastern time.

Interested investors can access the live audio webcast of the presentation by logging on to Waters Corporation's corporate website, in the investor relations' section.

Waters Corporation creates business advantages for laboratory- dependent organizations by delivering practical and sustainable innovation to enable significant advancements in such areas as healthcare delivery, environmental management, food safety, and water quality worldwide.

Pioneering a connected portfolio of separations science, laboratory information management, mass spectrometry and thermal analysis, Waters technology breakthroughs and laboratory solutions provide an enduring platform for customer success.

With revenue of $1.47 billion in 2007 and 5,000 employees, Waters is driving scientific discovery and operational excellence for customers worldwide.

CONTACT: Waters Corporation
Gene Cassis, 508-482-2349
V.P. Investor Relations

SOURCE: Waters Corporation